Browsing by Author Jeyaneethi, J
Showing results 4 to 10 of 10
< previous
Issue Date | Title | Author(s) |
---|---|---|
2-Sep-2020 | H2A Histone Family Member X (H2AX) Is Upregulated in Ovarian Cancer and Demonstrates Utility as a Prognostic Biomarker in Terms of Overall Survival | Saravi, S; Katsuta, E; Jeyaneethi, J; Amin, HA; Kaspar, M; Takabe, K; Pados, G; Drenos, F; Hall, M |
10-Aug-2020 | Identification of Cancer-Associated Circulating Cells in Anal Cancer Patients | Carter, TJ; Jeyaneethi, J; Kumar, J; Karteris, E; Glynne-Jones, R; Hall, M |
8-Nov-2017 | Identification of novel cancer biomarkers of prognostic value using specific gene regulatory networks (GRN): a novel role of RAD51AP1 for ovarian and lung cancers | Chudasama, D; Bo, V; Hall, M; Anikin, V; Jeyaneethi, J; Gregory, J; Pados, G; Tucker, A; Harvey, A; Pink, R; Karteris, E |
5-May-2021 | Identification of Potential Bisphenol A (BPA) Exposure Biomarkers in Ovarian Cancer | Zahra, A; Dong, Q; Hall, M; Jeyaneethi, J; Silva, E; Karteris, E; Sisu, C |
2018 | Involvement of the glutamine RF-amide peptide (QRFP) and its cognate receptor GPR103 in prostate cancer | Karteris, E; Kawan, M; Kyrou, I; Ramanjaneya, M; Williams, K; Jeyaneethi, J; Randeva, H |
9-Jul-2021 | A pancancer overview of FBN1, asprosin and its cognate receptor OR4M1 with detailed expression profiling in ovarian cancer | Kerslake, R; Hall, M; Vagnarelli, P; Jeyaneethi, J; Randeva, HS; Pados, G; Kyrou, I; Karteris, E |
9-Jul-2019 | Surfactant Protein D as a Potential Biomarker and Therapeutic Target in Ovarian Cancer | Karteris, E; Kumar, J; Murugaiah, V; Sotiriadis, G; Kaur, A; Jeyaneethi, J; Sturniolo, I; Alhamlan, F; Chatterjee, J; Hall, M; Kishore, U |